What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study, Observational).

August 22, 2025Open Access

Mutations in PLA2G6 impair ER–mitochondria contacts and ceramide homeostasis via GRP75 in Parkinson’s disease

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis revealed impaired mitochondria-Ca²⁺ transfer in Parkinson’s disease, highlighting GRP75's role and ceramide accumulation.

Loss of pla2g6 leads to disrupted er-mitochondria contacts and accumulated ceramide levels, driving neurodegeneration.
Key findings indicate that loss of gr75 levels and impaired mitochondrial function occur in pla2g6 mutant mice.
Research employed pla2g6 knockout models and patient-derived neurons using pharmacological assays to assess mitochondrial dynamics.
Findings may enable therapeutic strategies targeting ceramide modulation or gr75 restoration for parkinson's disease.

Liu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

August 22, 2025Open Access

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis revealed impaired mitochondria-Ca²⁺ transfer in Parkinson’s disease, highlighting GRP75's role and ceramide accumulation.

Loss of pla2g6 leads to disrupted er-mitochondria contacts and accumulated ceramide levels, driving neurodegeneration.
Key findings indicate that loss of gr75 levels and impaired mitochondrial function occur in pla2g6 mutant mice.
Research employed pla2g6 knockout models and patient-derived neurons using pharmacological assays to assess mitochondrial dynamics.
Findings may enable therapeutic strategies targeting ceramide modulation or gr75 restoration for parkinson's disease.

Liu et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark